Development of a Power Training Program to Improve Mobility in Older Veterans
2 other identifiers
interventional
30
1 country
1
Brief Summary
The overall purpose of this study is to develop a power training intervention in partnership with Veterans participating in Gerofit and to evaluate the program's acceptability, feasibility, and preliminary participant outcomes (leg power, physical function and self-report participation).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2026
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 29, 2025
CompletedFirst Posted
Study publicly available on registry
October 7, 2025
CompletedStudy Start
First participant enrolled
April 6, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2030
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2030
October 7, 2025
September 1, 2025
4.5 years
September 29, 2025
September 29, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Adherence
Adherence will be measured as a proportion of the number of sessions attended out of the number prescribed per protocol.
assessed at 3-months (primary endpoint) and 6 months in both intervention and standard of care groups
Secondary Outcomes (11)
Retention
assessed at 3-months (primary) and 6 months
Feasibility
assessed at 3-months (primary) and 6 months
Acceptability
assessed at 3-months (primary) and 6 months
Leg Press Power
baseline, 3-months and 6 months
4 stair climb power test (4SCPT)
baseline, 3-months and 6 months
- +6 more secondary outcomes
Study Arms (2)
Gerofit Power Training Intervention
EXPERIMENTALThis group will be randomized to receive Gerofit power training intervention for 6 months. They will receive power training as part of each Gerofit exercise session. Gerofit exercise sessions also include aerobic, flexibility, and balance training.
Gerofit Standard of Care
ACTIVE COMPARATORThis group will be randomized to receive standard of care exercise Gerofit exercise prescription for 6 months. Standard of care exercise for the Gerofit program includes combined aerobic, strength, flexibility and balance training.
Interventions
Gerofit Power Training will include a power training exercise prescription which will focus on having participants perform concentric portions of each resistance exercise as fast and as safely as possible with the eccentric component performed in a slow and controlled manner. The target dose of the power training intervention is 40-60% of the participant's 1-repetition maximum for 4-6 repetitions across 3-6 sets for each exercise. Exercises will focus on the major groups of the upper and lower body. All other Gerofit program components (balance, aerobic, and flexibility) will be consistent with the standard of care group. Sessions will be the same duration as the standard of care Gerofit group (60-75 minutes). The power training and standard of care groups will only differ in the form of resistance training performed.
Gerofit standard of care is a 60-75 minute multimodal exercise program which includes 20-30 minutes of aerobic training, traditional strength training of the major upper and lower body muscle groups (1-3 sets of 8-12 repetitions at moderate load), flexibility training and balance training.
Eligibility Criteria
You may qualify if:
- Pilot Study Criteria:
- Veterans 65 years of age and older
- New enrollees of the Rocky Mountain Regional Gerofit Program
- ability to function independently in a group setting
You may not qualify if:
- inability to perform basic activities of daily living
- oxygen dependency
- unstable cardiac disease
- moderate to severe cognitive impairment (Montreal cognitive assessment scores \< 24)
- proliferative diabetic retinopathy
- inability to ambulate
- progressive neurological diagnoses (e.g. Amyotrophic lateral sclerosis, Parkinson's disease, multiple sclerosis)
- individuals with planned orthopedic surgeries in the next 3 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Rocky Mountain Regional VA Medical Center, Aurora, CO
Aurora, Colorado, 80045-7211, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Mattie E Pontiff, PT, DPT, PhD
Rocky Mountain Regional VA Medical Center, Aurora, CO
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 29, 2025
First Posted
October 7, 2025
Study Start
April 6, 2026
Primary Completion (Estimated)
September 30, 2030
Study Completion (Estimated)
December 31, 2030
Last Updated
October 7, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share